Institutsleitung
Über
Prof. Dr. Bernd Neumaiers Forschung fokussiert sich auf die Entwicklung neuartiger und hocheffizienter 18F-Fluorierungsstrategien. Unter seiner Leitung entwickelt das Institut neuartige PET-Liganden, die zur interdisziplinären Aufklärung der Hirnfunktion und der zugrundeliegenden Mechanismen neurodegenerativer Erkrankungen beitragen. Ein weiterer Forschungsbereich umfasst die Herstellung und Trennung von Nicht-Standard-Radionukliden für die klinische Anwendung in der Endoradiotherapie. Darüber hinaus wurden in Zusammenarbeit mit den Universitätskliniken in Aachen, Bonn, Köln und Düsseldorf mehrere weitere Tracer für die Tumorbildgebung entwickelt.
Forschungsthemen
Neurotracer, Nicht-Standard Radionuklide, Nukleare Datenmessung, Radiopharmakologie, Radioliganden, Radiotracer
Lebenslauf
Academic Education and Prefessional Degrees
1992 | Diploma thesis: “Radiochemical determination of 7Be yields in the nuclear reaction 209Bi(p,7Be)203Hg up to 40 MeV”; Forschungszentrum Jülich GmbH |
1992 - 1996 | Dissertation: “Radiochemical studies on protein binding and affinity of Y(III)-complexes to bone metastases”; Forschungszentrum Jülich GmbH |
2009 | Habilitation and venia legendi in Nuclear Chemistry, Univ. Cologne |
Professional Career and Academic Achievements
1996 - 2006 | Head of Cyclotron/Radiopharmacy, University of Ulm |
2006 - 2013 | Head of Cyclotron/Radiopharmacy, Max-Planck-Institute for Neurological Research, Cologne |
2009 | Habilitation and venia legendi in Nuclear Chemistry, University of Cologne Habilitation thesis: “Development of radiometal-labelled antibodies and nucleosides for endoradiotherapy of oncological diseases” |
2010 | Offer of a W3-Professorship for Radiopharmaceutical Chemistry, Ruprecht Karls University Heidelberg with German Research Cancer Center (DKFZ) (declined) |
2011 | Adjunct Professor, University of Cologne |
Since 2013 | Professor (W3) for Nuclear Chemistry and Director at the Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital of Cologne |
Since 2015 | Professor (W3) for Nuclear Chemistry and Director of INM-5, Forschungszentrum Jülich GmbH |
Others (Editorships, Advisory Boards, Awards)
2009 - 2018 | Member of the Committee of the working group Radiochemistry/ Radiopharmacy (AGRR) of the German Society for Nuclear Medicine (DGN) |
2011 - 2018 | Member of the Board of Directors, German Society for Nuclear Medicine (DGN) |
2011 | Award winner of the innovative contest “365 Orte im Land der Ideen” for the project “Innovative imaging methods for the visualisation of stem cells in brain” |
Since 2015 | Member of the Radiopharmaceutical Working Group of the Pharmaceutical Chemistry Committee of the German Pharmacopoeia Commission |
2016 | SNMMI Image of the Year 2016 |
2017 - 2020 | Member of the Expert Group 14 (Radiopharmaceutical preparations) of the European Pharmacopoeia Commission |
Since 2019 | Member of the Board of Directors of the specialist group Nuclear Chemistry, German Chemical Society (GDCh) |
Associate Editor of the Journal of Radioanalytical and Nuclear Chemistry (JRNC) |